Travere Therapeutics (TVTX) Assets (2011 - 2026)
Travere Therapeutics (TVTX) reported Assets of $799.36 million for Q2 2026, up 43.9% from $555.31 million a year earlier and up 44.0% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Travere Therapeutics posted Assets of $605.19 million, up 1.9% from FY2024.
- Assets has a five-year compound annual growth rate of -0.1% (FY2020 to FY2025).
- By year, Assets came in at $594.13 million in FY2024 (-24.7%), $788.91 million in FY2023 (+17.3%), $672.59 million in FY2022 (-13.4%) and $776.63 million in FY2021 (+27.9%).
- The Q2 2026 figure ranks as the highest quarterly Assets since Q3 2023.
- Year over year, Assets has now increased in each of the last five quarters, with an average decline of 3.4% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q2 2026 (growth of 43.9%); the low point was Q3 2024 (a decline of 39.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $555.19 million (Q1 2026), $605.19 million (Q4 2025) and $538.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Travere Therapeutics | 5.80 Bn | 5.40 Bn | 167.41 Mn | 799.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 799.36 Mn |
| Mar 31, 2026 | 555.19 Mn |
| Dec 31, 2025 | 605.19 Mn |
| Sep 30, 2025 | 538.58 Mn |
| Jun 30, 2025 | 555.31 Mn |
| Mar 31, 2025 | 548.80 Mn |
| Dec 31, 2024 | 594.13 Mn |
| Sep 30, 2024 | 504.41 Mn |
| Jun 30, 2024 | 551.12 Mn |
| Mar 31, 2024 | 663.55 Mn |
| Dec 31, 2023 | 788.91 Mn |
| Sep 30, 2023 | 832.85 Mn |
| Jun 30, 2023 | 736.43 Mn |
| Mar 31, 2023 | 808.23 Mn |
| Dec 31, 2022 | 672.59 Mn |
| Sep 30, 2022 | 726.22 Mn |
| Jun 30, 2022 | 779.49 Mn |
| Mar 31, 2022 | 828.41 Mn |
| Dec 31, 2021 | 776.63 Mn |
| Sep 30, 2021 | 775.08 Mn |
API Access
Travere Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();